NDC 0069-0411
TicoVac
Tick-borne Encephalitis Vaccine
TicoVac is a Intramuscular Injection in the Vaccine category. It is labeled and distributed by Pfizer Laboratories Div Pfizer Inc. The primary component is Tick-borne Encephalitis Purified Antigen (formaldehyde Inactivated).
| Product ID | 0069-0411_14303a28-3771-4427-8a34-fe3eddb72f70 |
| NDC | 0069-0411 |
| Product Type | Vaccine |
| Proprietary Name | TicoVac |
| Generic Name | Tick-borne Encephalitis Vaccine |
| Dosage Form | Injection |
| Route of Administration | INTRAMUSCULAR |
| Marketing Start Date | 2021-10-25 |
| Marketing Category | BLA / |
| Application Number | BLA125740 |
| Labeler Name | Pfizer Laboratories Div Pfizer Inc |
| Substance Name | TICK-BORNE ENCEPHALITIS PURIFIED ANTIGEN (FORMALDEHYDE INACTIVATED) |
| Active Ingredient Strength | 2 ug/.5mL |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
Packaging
NDC 0069-0411-02
1 SYRINGE in 1 CARTON (0069-0411-02) > .5 mL in 1 SYRINGE (0069-0411-01)
| Marketing Start Date | 2021-10-25 |
| NDC Exclude Flag | N |
| Sample Package? | N |
Drug Details
NDC Crossover Matching brand name "TicoVac" or generic name "Tick-borne Encephalitis Vaccine"
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0069-0297 | TicoVac | Tick-Borne Encephalitis Vaccine |
| 0069-0411 | TicoVac | Tick-Borne Encephalitis Vaccine |
Trademark Results [TicoVac]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 TICOVAC 88797925 not registered Live/Pending |
Pfizer Ireland Pharmaceuticals 2020-02-14 |
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.